Condition
Multiple System Atrophy - Parkinsonian Subtype (MSA-P) clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Multiple System Atrophy - Parkinsonian Subtype (MSA-P) clinical trials that are recruiting, at sites in 3 countries (most in China (2), Switzerland (1), United States (1)). By phase: Phase 1 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Multiple System Atrophy - Parkinsonian Subtype (MSA-P) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Single NouvNeu001 (dopaminergic progenitor cells) injection for MSA-P | Phase 1 | Beijing, Beijing Municipality | Recruiting | Dec 17, 2025 |
| Epidural electrical stimulation to manage low blood pressure in Parkinson's disease | — | Lausanne, Canton of Vaud | Recruiting | Apr 9, 2025 |
| Aleeto for Parkinsonian multiple system atrophy (MSA-P) | Early Phase 1 | Beijing, Beijing Municipality | Recruiting | Jan 9, 2025 |
| Genetic program for Progressive Supranuclear Palsy and related conditions | — | Boston, Massachusetts | Recruiting | Oct 18, 2024 |
All recruiting trials (4)
-
Single NouvNeu001 (dopaminergic progenitor cells) injection for MSA-P
This Phase I trial will test whether a single injection of NouvNeu001 (human dopaminergic progenitor cells) is safe and may help people aged 30–70 with early Multiple System Atrophy, Parkinsonian subtype.
-
Epidural electrical stimulation to manage low blood pressure in Parkinson's disease
This study will try epidural electrical stimulation (ARC-IM) to see if it helps people with typical or atypical Parkinson's disease who have symptomatic orthostatic hypotension.
-
Aleeto for Parkinsonian multiple system atrophy (MSA-P)
This study will test whether Aleeto is safe and might help people with the Parkinsonian form of multiple system atrophy.
-
Genetic program for Progressive Supranuclear Palsy and related conditions
This study is collecting DNA from adults with Progressive Supranuclear Palsy and similar conditions to see how genetics might help improve diagnosis and care for patients.
Related topics
Quick answers
How many Multiple System Atrophy - Parkinsonian Subtype (MSA-P) clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (2 trials), Switzerland (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.